Skip to content
中文产业新闻· 江西省医疗保障局·· 1 day agoScore73

Jiangxi Healthcare Security Bureau Seeks Public Comment on Dual-Channel Drug Classification and Filing Materials

In brief

On October 19, 2026, the Jiangxi Provincial Healthcare Security Administration opened public consultation on the classification of 'dual-channel' drugs and the list of filing materials. National negotiated drugs will be sorted into classes A, B and C based on criteria including per-course treatment cost, with the 2026 rural and urban resident catastrophic insurance deductible as the baseline. Written comments close on October 25, 2026, and innovative drug qualification documents are due by November 14, 2026.

Source: 中文产业新闻 · ybj.jiangxi.gov.cn

CBACBA Frontier Insights (CFI)Chinese Biopharmaceutical Association (CBA)www.cba-usa.org